|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2002-9-4
|
|
pubmed:abstractText |
The pathogenetic role of B cells in rheumatoid arthritis (RA) is under debate, but it is currently believed to be marginal. The availability of selective anti-B cell treatment provides a unique opportunity to clarify this issue. This study was undertaken to investigate the effects of B cell blockade in the treatment of refractory RA, and to evaluate the implications with regard to the role of B cells in the disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2029-33
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12209504-Aged,
pubmed-meshheading:12209504-Antibodies, Monoclonal,
pubmed-meshheading:12209504-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:12209504-Antigens, CD20,
pubmed-meshheading:12209504-Antineoplastic Agents,
pubmed-meshheading:12209504-Arthritis, Rheumatoid,
pubmed-meshheading:12209504-B-Lymphocytes,
pubmed-meshheading:12209504-Cytotoxicity, Immunologic,
pubmed-meshheading:12209504-Female,
pubmed-meshheading:12209504-Humans,
pubmed-meshheading:12209504-Immunosuppression,
pubmed-meshheading:12209504-Infusions, Intravenous,
pubmed-meshheading:12209504-Middle Aged,
pubmed-meshheading:12209504-Treatment Outcome
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells.
|
|
pubmed:affiliation |
University of Udine, Udine, Italy. gf.ferraccioli@med.uniud.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
